Patient Experience of Symptoms and Side Effects when Treated with Osimertinib for Advanced Non-Small-Cell Lung Cancer: A Qualitative Interview Substudy

被引：0
作者：
Anna Rydén
Fiona Blackhall
Hye Ryun Kim
Rathi N. Pillai
Lauren Braam
Mona L. Martin
Andrew Walding
机构：
[1] AstraZeneca Gothenburg,Division of Molecular and Clinical Cancer Sciences
[2] University of Manchester,Department of Medical Oncology, Yonsei Cancer Center
[3] The Christie NHS Foundation Trust,Department of Hematology and Medical Oncology, School of Medicine
[4] Yonsei University College of Medicine,undefined
[5] Winship Cancer Institute of Emory University,undefined
[6] Health Research Associates Inc.,undefined
[7] AstraZeneca R&D,undefined
来源：
The Patient - Patient-Centered Outcomes Research | 2017年 / 10卷
关键词：
Epidermal Growth Factor Receptor; Initial Interview; Poor Appetite; Bothersome Symptom; Transcript Database;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：593 / 603
页数：10
相关论文
共 50 条
[31]   Osteoblastic Bone Reaction in Non-small Cell Lung Cancer Harboring Epidermal Growth Factor Receptor Mutations Treated with Osimertinib [J].
Kanaoka, K. ;
Sumikawa, H. ;
Tamiya, A. ;
Inagaki, Y. ;
Taniguchi, Y. ;
Nakao, K. ;
Matsuda, Y. ;
Okishio, K. .
JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) :S666-S666
[32]   Evaluation of osimertinib for advanced non-small cell lung cancer with leptomeningeal metastases: a cost-effectiveness and budget impact analysis [J].
Shaohong Luo ;
Xiuhua Weng ;
Shen Lin ;
Xiaoting Huang ;
Lingning Huang ;
Wei Zhou ;
Xianzhong Guo ;
Xiongwei Xu .
International Journal of Clinical Pharmacy, 2022, 44 :192-200
[33]   Osteoblastic bone reaction in non-small cell lung cancer harboring epidermal growth factor receptor mutation treated with osimertinib [J].
Kensuke Kanaoka ;
Hiromitsu Sumikawa ;
Shunsuke Oyamada ;
Akihiro Tamiya ;
Yuji Inagaki ;
Yoshihiko Taniguchi ;
Keiko Nakao ;
Yoshinobu Matsuda ;
Kyoichi Okishio .
BMC Cancer, 23
[34]   Osteoblastic bone reaction in non-small cell lung cancer harboring epidermal growth factor receptor mutation treated with osimertinib [J].
Kanaoka, Kensuke ;
Sumikawa, Hiromitsu ;
Oyamada, Shunsuke ;
Tamiya, Akihiro ;
Inagaki, Yuji ;
Taniguchi, Yoshihiko ;
Nakao, Keiko ;
Matsuda, Yoshinobu ;
Okishio, Kyoichi .
BMC CANCER, 2023, 23 (01)
[35]   Evaluation of osimertinib for advanced non-small cell lung cancer with leptomeningeal metastases: a cost-effectiveness and budget impact analysis [J].
Luo, Shaohong ;
Weng, Xiuhua ;
Lin, Shen ;
Huang, Xiaoting ;
Huang, Lingning ;
Zhou, Wei ;
Guo, Xianzhong ;
Xu, Xiongwei .
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2022, 44 (01) :192-200
[36]   Epidermal Growth Factor Receptor Mutation Status and Adjuvant Chemotherapy in Resected Advanced Non-Small-Cell Lung Cancer [J].
Sun, Hai-bo ;
Ou, Wei ;
Li, Yin ;
Fang, Qin ;
Qin, Jianjun ;
Zhang, Liang ;
Wang, Si-yu .
CLINICAL LUNG CANCER, 2013, 14 (04) :376-382
[37]   Health-related quality of life in patients undergoing drug therapy for advanced non-small-cell lung cancer [J].
Fallowfield, LJ ;
Harper, P .
LUNG CANCER, 2005, 48 (03) :365-377
[38]   Impact of pre-existing interstitial lung abnormal shadow on lung injury development and severity in patients of non-small cell lung cancer treated with osimertinib [J].
Shibaki, Ryota ;
Ozawa, Yuichi ;
Noguchi, Susumu ;
Murakami, Yusuke ;
Takase, Eri ;
Azuma, Yuichiro ;
Maebeya, Masaru ;
Sugimoto, Takeya ;
Hayata, Atsushi ;
Hayakawa, Takahiro ;
Tamaki, Shinya ;
Nakanishi, Masanori ;
Teraoka, Shunsuke ;
Akamatsu, Hiroaki .
CANCER MEDICINE, 2022, 11 (20) :3743-3750
[39]   Asian ethnicity as a predictor of response in patients with non-small-cell lung cancer treated with gefitinib on an expanded access program [J].
Thomas, Sheeba K. ;
Fossella, Frank V. ;
Liu, Diane ;
Schaerer, Rainell ;
Tsao, Anne S. ;
Kies, Merrill S. ;
Pisters, Katherine M. ;
Blumenschein, George R., Jr. ;
Glisson, Bonnie S. ;
Lee, J. Jack ;
Herbst, Roy S. ;
Zinner, Ralph G. .
CLINICAL LUNG CANCER, 2006, 7 (05) :326-331
[40]   Near-Complete Response to Osimertinib for Advanced Non-Small-Cell Lung Cancer in a Pretreated Patient Bearing Rare Compound Exon 20 Mutation (S768I+V774M): A Case Report [J].
Cosi, Donato Michele ;
Fragale, Cristina ;
Magri, Chiara ;
Carnevale, Aldo ;
Ciancetta, Antonella ;
Guidoboni, Massimo ;
Negrini, Massimo ;
Bronte, Giuseppe ;
Calabro, Luana .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (14)
12345